These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings

Labcorp Holdings Inc. reported robust second-quarter 2025 results, with adjusted EPS of $4.35 and sales of $3.53 billion, both significantly exceeding analyst consensus estimates. Driven by strong performance and margin expansion, the company subsequently raised its full-year 2025 adjusted earnings and sales guidance. This positive outlook spurred a 6.9% gain in Labcorp shares and led to increased price targets from analysts including Baird and Morgan Stanley, signaling strong investor confidence.

Analysis

Labcorp Holdings Inc. delivered a robust second quarter for 2025, outperforming consensus estimates on both revenue and earnings. The company reported adjusted EPS of $4.35 against a consensus of $4.17, while sales grew 9.5% year-over-year to $3.53 billion, beating the expected $3.485 billion. According to CEO Adam Schechter, this performance was driven by topline growth and expanding margins across both business segments. Based on this momentum, Labcorp raised its full-year 2025 guidance for both adjusted EPS to a range of $16.05-$16.50 and sales to $14.08 billion-$14.23 billion, positioning its new forecasts above prior market consensus. The positive results and outlook triggered a 6.9% increase in the stock price to $267.69 and prompted bullish analyst revisions, with Baird and Morgan Stanley raising their price targets to $302 and $306, respectively, while maintaining their positive ratings.

Key Decisions for Investors

• The strong earnings beat coupled with a significant upward revision of full-year guidance suggests a positive fundamental trajectory, supporting a bullish outlook for investors considering or holding the stock.
• Investors should monitor the company's ability to sustain the margin expansion and operational momentum cited by management into the second half of the year to validate the new, higher guidance.
• The updated analyst price targets of $302 and $306, which indicate substantial upside from the current price, can serve as a near-term valuation benchmark for assessing entry or exit points.